0.2382
0.75%
-0.0018
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BNGO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.24
Offen:
$0.2401
24-Stunden-Volumen:
2.13M
Relative Volume:
0.93
Marktkapitalisierung:
$24.80M
Einnahmen:
$36.12M
Nettoeinkommen (Verlust:
$-232.49M
KGV:
-0.0149
EPS:
-16.0015
Netto-Cashflow:
$-126.87M
1W Leistung:
+13.75%
1M Leistung:
-22.11%
6M Leistung:
-77.74%
1J Leistung:
-84.43%
Bionano Genomics Inc Stock (BNGO) Company Profile
Firmenname
Bionano Genomics Inc
Sektor
Telefon
(858) 888-7600
Adresse
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Vergleichen Sie BNGO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
0.2382 | 24.80M | 36.12M | -232.49M | -126.87M | -16.00 |
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-11-15 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
2024-09-10 | Herabstufung | BTIG Research | Buy → Neutral |
2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
2022-12-12 | Fortgesetzt | BTIG Research | Buy |
2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
2021-06-16 | Eingeleitet | BTIG Research | Buy |
2020-09-24 | Eingeleitet | Ladenburg Thalmann | Buy |
2020-04-08 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Bionano Genomics Inc Aktie (BNGO) Neueste Nachrichten
Bionano Genomics stock hits 52-week low at $0.2 By Investing.com - Investing.com Australia
Bionano Genomics stock hits 52-week low at $0.2 - Investing.com
BNGO (Bionano Genomics) Accumulated other comprehensive inc - GuruFocus.com
BNGO (Bionano Genomics) 50-Day SMA : $0.35 (As of Nov. 20, 2024) - GuruFocus.com
BNGO (Bionano Genomics) 6-Month Price Index : 0.20 (As of Nov. 20, 2024) - GuruFocus.com
Bionano Genomics (FRA:2Y30) Operating Margin % : -372.57% (As of Sep. 2024) - GuruFocus.com
BTIG maintains neutral on BNGO shares amid Q3 results and strategy shift - Investing.com
Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2024 Earnings Call Transcript - Insider Monkey
Bionano Genomics Inc (BNGO) Quarterly 10-Q Report - Quartzy
Ladenburg Thalmann Downgrades Bionano Genomics (BNGO) - MSN
Bionano Genomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Bionano Genomics stock hits 52-week low at $0.26 By Investing.com - Investing.com Australia
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress - The Manila Times
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: St - GuruFocus.com
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... By GuruFocus - Investing.com Canada
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... - Yahoo Finance
Optical Genome Mapping Market Size, Share, Trends, - openPR
Bionano Genomics Sees Growth in OGM Adoption - TipRanks
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript - MSN
Bionano Genomics Q3 Revenue Falls 35% Despite OGM System Growth; Reports Mixed Results | BNGO Stock News - StockTitan
Bionano Genomics stock hits 52-week low at $0.26 - Investing.com
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024 - Barchart
Earnings Outlook For Bionano Genomics - Benzinga
U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.67% - Investing.com
Asia stocks fall as China stimulus disappoints, deflation persists - Investing.com
XRP Climbs 10.07% In Bullish Trade - Investing.com UK
Bionano Genomics Inc (BNGO): Major Improvements, Worth A Look - Stocks Register
Bionano Genomics (BNGO) Sets Q3 2024 Earnings Call for November 13 | BNGO Stock News - StockTitan
Optical Genome Mapping Market to Witness 26.76% CAGR During - GlobeNewswire
Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030Consumables and Reagents to Register High GrowthBionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry - Yahoo Canada Finance
Bionano Genomics Announces $3 Million Registered Direct OfferingSAN DIEGO, Oct. 31, 2024 – Bionano Genomics, Inc. (Nasdaq: BNGO) recently finalized a definitive agreement with institutional investors for a registered direct offering. The of - Defense World
Bionano Genomics stock hits 52-week low at $0.27 By Investing.com - Investing.com Australia
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - The Manila Times
Bionano Genomics stock hits 52-week low at $0.27 - Investing.com India
BioNano Genomics Announces $3M Direct Offering Initiative - TipRanks
BNGOBionano Genomics, Inc. Latest Stock News & Market Updates - StockTitan
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - The Manila Times
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024 - The Manila Times
Waste Management (WM-N) QuotePress Release - The Globe and Mail
Bionano Genomics (STU:2Y30) Pre-Tax Income : €-189.69 Mil (TTM As of Jun. 2024) - GuruFocus.com
S&P 500 valuation suggests 1-2% price return over next decade: BofA - Investing.com
10 Best Penny Stocks to Invest in 2024 - Techopedia
Bionano Genomics' OGM outperforms in MYC gene study - Investing.com
Bionano Genomics' OGM outperforms in MYC gene study By Investing.com - Investing.com Canada
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma - StockTitan
Analysts Predict How High Bionano Genomics Inc (BNGO) Will Go. - Stocks Register
Bionano Genomics stock hits 52-week low at $0.3 amid market challenges - Investing.com
Taking on analysts’ expectations and winning: Bionano Genomics Inc (BNGO) - SETE News
BNGO Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
Bionano Genomics Inc (BNGO) deserves closer scrutiny - US Post News
Stock market today: S&P 500 closes above 5,800 for first time ever as banks rally - Investing.com
Finanzdaten der Bionano Genomics Inc-Aktie (BNGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):